Advanced search
Publication Cover
The American Journal of Drug and Alcohol Abuse
Encompassing All Addictive Disorders
Volume 26, 2000 - Issue 3
Submit an article Journal homepage
507
Views
56
CrossRef citations to date
0
Altmetric
Original

Double Jeopardy: Schizophrenia and Substance Use

Cheryl D. Swofford Department of Psychiatry and Behavioral Sciences, Grady Memorial Hospital, Emory University School of Medicine, Outpatient Psychiatry, Atlanta, Georgia
, M.A., M.S.,
Geri Scheller-Gilkey Department of Psychiatry and Behavioral Sciences,Grady Memorial Hospital, Emory University School of Medicine, Outpatient Psychiatry, Atlanta, Georgia; Department of Psychiatry at Grady, Emory University School of Medicine, Florida Hall, 60 Coca Cola Place, Atlanta, GA, 30335, U.S.A.
, Ph.D.,
Andrew H. Miller Department of Psychiatry and Behavioral Sciences, Grady Memorial Hospital, Emory University School of Medicine, Outpatient Psychiatry, Atlanta, Georgia
, M.D.,
Bobbi Woolwine Department of Psychiatry and Behavioral Sciences, Grady Memorial Hospital, Emory University School of Medicine, Outpatient Psychiatry, Atlanta, Georgia
, M.S.W. &
Rosalind Mance Department of Psychiatry and Behavioral Sciences, Grady Memorial Hospital, Emory University School of Medicine, Outpatient Psychiatry, Atlanta, Georgia
, M.B.B.S., M.R.C. Psych.
Pages 343-353 | Published online: 07 Jul 2009

Citations (56)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (11)

Kristiina Kivimies, Eila Repo-Tiihonen, Hannu Kautiainen, Päivi Maaranen, Leea H. Muhonen, Martti Heikkinen & Jari Tiihonen. (2016) Opioid abuse and hospitalization rates in patients with schizophrenia. Nordic Journal of Psychiatry 70:2, pages 128-132.
Read now
Luis San, Miquel Bernardo, Agustín Gómez & Mario Peña. (2013) Factors associated with relapse in patients with schizophrenia. International Journal of Psychiatry in Clinical Practice 17:1, pages 2-9.
Read now
Kristiina Kivimies, Eila Repo-Tiihonen & Jari Tiihonen. (2012) The Substance Use among Forensic Psychiatric Patients. The American Journal of Drug and Alcohol Abuse 38:4, pages 273-277.
Read now
Maju Mathew Koola, HeidiJ. Wehring & DeannaL. Kelly. (2012) The Potential Role of Long-Acting Injectable Antipsychotics in People With Schizophrenia and Comorbid Substance Use. Journal of Dual Diagnosis 8:1, pages 50-61.
Read now
Maurizio Pompili, Marco Innamorati, David Lester, HagopS. Akiskal, Zoltán Rihmer, Antonio Del Casale, Mario Amore, Paolo Girardi & Roberto Tatarelli. (2009) Substance Abuse, Temperament and Suicide Risk: Evidence from a Case-Control Study. Journal of Addictive Diseases 28:1, pages 13-20.
Read now
Philippe Huguelet, Laurence Borras, Christiane Gillieron, Pierre-Yves Brandt & Sylvia Mohr. (2009) Influence of Spirituality and Religiousness on Substance Misuse in Patients with Schizophrenia or Schizo-Affective Disorder. Substance Use & Misuse 44:4, pages 502-513.
Read now
Valborg Helseth, Tone Lykke-Enger, Jon Johnsen & Helge Waal. (2009) Substance use disorders among psychotic patients admitted to inpatient psychiatric care. Nordic Journal of Psychiatry 63:1, pages 72-77.
Read now
Evaristo Akerele & Frances R. Levin. (2007) Comparison of Olanzapine to Risperidone in Substance-Abusing Individuals with Schizophrenia. American Journal on Addictions 16:4, pages 260-268.
Read now
Stéphane Potvin, Amir Ali Sepehry & Emmanuel Stip. (2007) Meta-analysis of depressive symptoms in dual-diagnosis schizophrenia. Australian and New Zealand Journal of Psychiatry 41:10, pages 792-799.
Read now
Deborah S. Finnell. (2005) Building a Program of Research Based on the Transtheoretical Model. Journal of Addictions Nursing 16:1-2, pages 13-21.
Read now
Vanessa Crawford, Ilana B. Crome & Carmel Clancy. (2003) Co-existing Problems of Mental Health and Substance Misuse (Dual Diagnosis): a literature review. Drugs: Education, Prevention and Policy 10:1, pages 1-74.
Read now

Articles from other publishers (45)

Pierre-Michel Llorca, Philippe Nuss, Éric Fakra, Isabelle Alamome, Dominique Drapier, Wissam El Hage, Renaud Jardri, Stéphane Mouchabac, Marc Rabbani, Nicolas Simon, Marie-Noëlle Vacheron & Jean-Michel Azorin. (2022) Place of the partial dopamine receptor agonist aripiprazole in the management of schizophrenia in adults: a Delphi consensus study. BMC Psychiatry 22:1.
Crossref
Julia Sasiadek, Darby J.E. Lowe, Sarah-Maude Rioux & Tony P. George. 2021. Psychotic Disorders. Psychotic Disorders 107 124 .
Sara de la Salle, Lawrence Inyang, Danielle Impey, Dylan Smith, Joelle Choueiry, Renee Nelson, Jasmit Heera, Ashley Baddeley, Vadim Ilivitsky & Verner Knott. (2019) Acute separate and combined effects of cannabinoid and nicotinic receptor agonists on MMN-indexed auditory deviance detection in healthy humans. Pharmacology Biochemistry and Behavior 184, pages 172739.
Crossref
Kristiina Kivimies, Eila Repo-Tiihonen, Hannu Kautiainen & Jari Tiihonen. (2018) Comorbid opioid use is undertreated among forensic patients with schizophrenia. Substance Abuse Treatment, Prevention, and Policy 13:1.
Crossref
Glenn E. Hunt, Matthew M. Large, Michelle Cleary, Harry Man Xiong Lai & John B. Saunders. (2018) Prevalence of comorbid substance use in schizophrenia spectrum disorders in community and clinical settings, 1990–2017: Systematic review and meta-analysis. Drug and Alcohol Dependence 191, pages 234-258.
Crossref
Kimberlee J. Trudeau, Joanna Burtner, Albert J. Villapiano, Megan Jones, Stephen F. Butler & Kruti Joshi. (2018) Burden of Schizophrenia or Psychosis-Related Symptoms in Adults Undergoing Substance Abuse Evaluation. Journal of Nervous & Mental Disease 206:7, pages 528-536.
Crossref
Ek-uma Imkome. 2018. Drug Addiction. Drug Addiction.
Clementine Nordon, Thomas Bovagnet, Mark Belger, Javier Jimenez, Robert Olivares, Helene Chevrou-Severac, Helene Verdoux, Josep Maria Haro, Lucien Abenhaim & Helene Karcher. (2018) Trial exclusion criteria and their impact on the estimation of antipsychotic drugs effect: A case study using the SOHO database. Schizophrenia Research 193, pages 146-153.
Crossref
Manjunath Rajashekharaiah & Pravin Verma. (2016) COMPARISON OF SOCIODEMOGRAPHIC AND CLINICAL VARIABLES IN SCHIZOPHRENICS WITH AND WITHOUT SUBSTANCE ABUSE. Journal of Evolution of Medical and Dental Sciences 5:66, pages 4681-4686.
Crossref
Andrew K. Martin, Emily C. Gibson, Bryan Mowry & Gail A. Robinson. (2016) Verbal Initiation, Suppression, and Strategy Use and the Relationship with Clinical Symptoms in Schizophrenia. Journal of the International Neuropsychological Society 22:7, pages 735-743.
Crossref
Sourav Khanra, C.R.J. Khess & Naveen Srivastava. (2015) Chronic non-fatal Datura abuse in a patient of paranoid schizophrenia: A case report. Addictive Behaviors 43, pages 39-41.
Crossref
Kiersten L. Johnson, Sarah L. Desmarais, Marvin S. Swartz & Richard A. Van Dorn. (2015) Latent class analysis of discordance between results of drug use assessments in the CATIE data. Schizophrenia Research 161:2-3, pages 434-438.
Crossref
Nicole C. Turygin, Johnny L. Matson, Hilary L. Adams & Lindsey W. Williams. (2014) Co-occurring disorder clusters in adults with mild and moderate intellectual disability in residential treatment settings. Research in Developmental Disabilities 35:11, pages 3156-3161.
Crossref
F. J. van der Meer, J. H. Meijer, C. J. Meijer, W. van den Brink & E. Velthorst. (2013) Cognitive functioning associated with stimulant use in patients with non-affective psychosis, their unaffected siblings and healthy controls. Psychological Medicine 44:9, pages 1901-1911.
Crossref
Joanna Sweeting, Johan Duflou & Christopher Semsarian. (2013) Postmortem analysis of cardiovascular deaths in schizophrenia: A 10-year review. Schizophrenia Research 150:2-3, pages 398-403.
Crossref
Simeon Sender‐Galloway & Tom Clark. (2013) Problematic substance use among forensic psychiatric community patients. The Journal of Forensic Practice 15:2, pages 119-129.
Crossref
Anil Rane, Abhijit Nadkarni, Jaiprada Kanekar, Wenona Fernandes, Hirabai A. Borker & Yvonne Pereira. (2018) Alcohol use in schizophrenia: prevalence, patterns, correlates and clinical outcomes in Goa, India. The Psychiatrist 36:7, pages 257-262.
Crossref
Maryam Khojasteh-Fard, Mina Tabrizi & Mahsa M. Amoli. (2011) Is DNA methylation responsible for immune system dysfunction in schizophrenia?. Medical Hypotheses 77:4, pages 573-579.
Crossref
Thomas RE Barnes. (2011) Evidence-based guidelines for the pharmacological treatment of schizophrenia: recommendations from the British Association for Psychopharmacology. Journal of Psychopharmacology 25:5, pages 567-620.
Crossref
Ahmed El-Missiry, Ahmed Sayed Aboraya, Hader Manseur, Johnna Manchester, Cheryl France & Katherine Border. (2009) An Update on the Epidemiology of Schizophrenia with a Special Reference to Clinically Important Risk Factors. International Journal of Mental Health and Addiction 9:1, pages 39-59.
Crossref
W. Ben Makhlouf, C. Besbes & Z. El Hechmi. (2009) Doses d’entretien des neuroleptiques dans le traitement au long cours de la schizophrénie. Annales Médico-psychologiques, revue psychiatrique 167:10, pages 774-778.
Crossref
Stéphane Potvin, Pierre Blanchet & Emmanuel Stip. (2009) Substance abuse is associated with increased extrapyramidal symptoms in schizophrenia: A meta-analysis. Schizophrenia Research 113:2-3, pages 181-188.
Crossref
Krista Schladweiler, Pierre K. Alexandre & Donald M. Steinwachs. (2009) Factors associated with substance use problem among Maryland Medicaid enrollees affected by serious mental illness. Addictive Behaviors 34:9, pages 757-763.
Crossref
Paolo Olgiati, Laura Mandelli, Cristina Lorenzi, Elena Marino, Pirovano Adele, Barbara Ferrari, Diana De Ronchi & Alessandro Serretti. (2014) Schizophrenia: genetics, prevention and rehabilitation. Acta Neuropsychiatrica 21:3, pages 109-120.
Crossref
N. D. Volkow. (2009) Substance Use Disorders in Schizophrenia--Clinical Implications of Comorbidity. Schizophrenia Bulletin 35:3, pages 469-472.
Crossref
Massimiliano Piselli, Sandro Elisei, Nicola Murgia, Roberto Quartesan & Karen M. Abram. (2009) Co-occurring psychiatric and substance use disorders among male detainees in Italy. International Journal of Law and Psychiatry 32:2, pages 101-107.
Crossref
Alisa B. Busch, Anthony F. Lehman, Howard Goldman & Richard G. Frank. (2009) Changes Over Time and Disparities in Schizophrenia Treatment Quality. Medical Care 47:2, pages 199-207.
Crossref
Stéphane Potvin, Christian C. Joyal, Julie Pelletier & Emmanuel Stip. (2008) Contradictory cognitive capacities among substance-abusing patients with schizophrenia: A meta-analysis. Schizophrenia Research 100:1-3, pages 242-251.
Crossref
Robert W Robin, Irving I Gottesman, Bernard Albaugh & David Goldman. (2007) Schizophrenia and psychotic symptoms in families of two American Indian tribes. BMC Psychiatry 7:1.
Crossref
Samuel Keith. (2007) Dual Diagnosis of Substance Abuse and Schizophrenia: Improving Compliance with Pharmacotherapy. Clinical Schizophrenia & Related Psychoses 1:3, pages 259-269.
Crossref
Gerard Galluccci, Florence Hackerman, Gerald Nestadt, Peter V. Rabins, William W. Eaton & Jack Samuels. (2007) Cognitive Impairment in the Non-elderly: Validation of a New Tool to Assess Intellectual Disability in Community and Clinical Populations. Journal of Developmental and Physical Disabilities 19:5, pages 519-530.
Crossref
Diederik E. Tenback, Peter N. van Harten, Cees J. Slooff & Jim van Os. (2007) Worsening of psychosis in schizophrenia is longitudinally associated with tardive dyskinesia in the European Schizophrenia Outpatient Health Outcomes study. Comprehensive Psychiatry 48:5, pages 436-440.
Crossref
S. Farrelly, M. G. Harris, L. P. Henry, R. Purcell, A. Prosser, O. Schwartz, H. Jackson & P. D. McGorry. (2007) Prevalence and correlates of comorbidity 8 years after a first psychotic episode. Acta Psychiatrica Scandinavica 116:1, pages 62-70.
Crossref
Michael T. Compton, Paul S. Weiss, Joyce C. West & Nadine J. Kaslow. (2005) The associations between substance use disorders, schizophrenia-spectrum disorders, and Axis IV psychosocial problems. Social Psychiatry and Psychiatric Epidemiology 40:12, pages 939-946.
Crossref
Ann M. Mortimer. (2018) Another triumph of hope over experience?. Advances in Psychiatric Treatment 11:4, pages 277-285.
Crossref
Nicholas Seivewright, Charles McMahon & Paul Egleston. (2018) Stimulant use still going strong. Advances in Psychiatric Treatment 11:4, pages 262-269.
Crossref
TapasK Aich, VinodK Sinha, ChristodayR. J Khess & Sahilja Singh. (2005) Substance abuse co-morbidity in schizophrenia: An inpatient study of course and outcome. Indian Journal of Psychiatry 47:1, pages 33.
Crossref
E. Gouzoulis-Mayfrank. (2004) Doppeldiagnose Psychose und SuchtDual diagnosis of psychosis and addiction. Der Nervenarzt 75:7, pages 642-650.
Crossref
Tom Waller & Daphne Rumball. 2004. Treating Drinkers and Drug Users in the Community. Treating Drinkers and Drug Users in the Community 409 448 .
Sandra L Tunis, Haya Ascher-Svanum, Michael Stensland & Bruce J Kinon. (2004) Assessing the Value of Antipsychotics for Treating Schizophrenia. PharmacoEconomics 22:1, pages 1-8.
Crossref
Ene-Choo Tan, Siow-Ann Chong, Rathi Mahendran, Chay Hoon Tan & Yik-Ying Teo. (2003) Mu opioid receptor gene polymorphism and neuroleptic-induced tardive dyskinesia in patients with schizophrenia. Schizophrenia Research 65:1, pages 61-63.
Crossref
Grad C. Green. (2016) Guidelines for Assessing and Diagnosing Acute Psychosis: A Primer. Journal of the American Psychiatric Nurses Association 8:6_suppl, pages S31-S35.
Crossref
Renee D. Goodwin & Deborah S. Hasin. (2002) Sedative use and misuse in the United States. Addiction 97:5, pages 555-562.
Crossref
EVARISTO O. AKERELE & FRANCES R. LEVIN. (2002) Substance Abuse Among Patients with Schizophrenia. Journal of Psychiatric Practice 8:2, pages 70-80.
Crossref
Wayne S. Fenton. (2001) Comorbid conditions in schizophrenia. Current Opinion in Psychiatry 14:1, pages 17-23.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.